| Literature DB >> 34950421 |
Thomas Zheng Jie Teng1, Xuan Rong Thong1, Kai Yuan Lau1, Sunder Balasubramaniam1, Vishal G Shelat1.
Abstract
Being one of the most common causes of the acute abdomen, acute appendicitis (AA) forms the bread and butter of any general surgeon's practice. With the recent advancements in AA's management, much controversy in diagnostic algorithms, possible differential diagnoses, and weighing the management options has been generated, with no absolute consensus in the literature. Since Alvarado described his eponymous clinical scoring system in 1986 to stratify AA risk, there has been a burgeoning of additional scores for guiding downstream management and mortality assessment. Furthermore, advancing literature on the role of antibiotics, variations in appendicectomy, and its adjuncts have expanded the surgeon's repertoire of management options. Owing to the varied presentation, diagnostic tools, and management of AA have also been proposed in special groups such as pregnant patients, the elderly, and the immunocompromised. This article seeks to raise the critical debates about what is currently known about the above aspects of AA and explore the latest controversies in the field. Considering the ever-evolving coronavirus disease 2019 situation worldwide, we also discuss the pandemic's repercussions on patients and how surgeons' practices have evolved in the context of AA. ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.Entities:
Keywords: Advances; Appendicitis; COVID-19; Controversy; Diagnosis; Management
Year: 2021 PMID: 34950421 PMCID: PMC8649565 DOI: 10.4240/wjgs.v13.i11.1293
Source DB: PubMed Journal: World J Gastrointest Surg
Various scoring systems for acute appendicitis
|
|
|
|
|
|
|
| |
| Alvarado | - | RIF tenderness (2); Elevated temperature (1); Rebound tenderness (1); Migration of pain to RIF (1); Anorexia (1); Nausea or vomiting (1) | Leucocytosis (2); Leukocyte left shift (1) | 94.1% | 90.4% | 1-4: Discharge; 5-6: Admit and observe; 7-10: Surgery | |
| AIR | - | Elevated temperature (1); Rebound tenderness: Light (1), medium (2), strong (3); RIF pain (1); Vomiting (1) | Leucocytosis, × 109/L: 10-14.9 (1); ≥ 15 (2); Polymorphonuclear leucocytosis, %: 70-84 (1); ≥ 85 (2); CRP level, mg/L: 10-49 (1); ≥ 50 (2) | 97% | 0-4: Outpatient follow-up; 5-8: Admit and observe; 9-12: Surgery | ||
| AAS | - | RIF tenderness: Women 16-49 yr (1); all other patients (3); Migration of pain (2); RIF pain (2); Guarding: Mild (2); moderate or severe (4) | Leucocytosis, × 109/L: ≥ 7.2 and < 10.9 (1); ≥ 10.9 and < 14.0 (2); ≥ 14.0 (3). Neutrophilia, %: ≥ 62 and < 75 (2); ≥ 75 and < 83 (3); ≥ 83 (4). CRP level, mg/L and symptoms < 24 h: ≥ 4 and < 11 (2); ≥ 11 and < 25 (3); ≥ 25 and < 83 (5); ≥ 83 (1). CRP level, mg/L and symptoms > 24 h: ≥ 12 and < 53 (2); ≥ 53 and < 152 (2); ≥ 152 (1) | 1-10: Discharge without imaging; 11-15: Imaging; ≥ 16: Surgery | |||
| RIPASA | Age: < 40 (1); Age > 40 (0.5). Gender: Male (1); female (0.5). Foreign nationality registration identity card (1) | RIF tenderness (1); Elevated temperature (1); Rebound tenderness (1); Migration of pain to RIF (0.5); Anorexia (1); Nausea or vomiting (1); RIF pain (0.5); Duration of symptoms: < 48 h (1); > 48 h (0.5); Guarding (2); Rovsing sign (2) | Leucocytosis (1); Negative urine analysis (1) | 91.67% | 93.18% | - | |
| Ohmann | Age < 50 (1.5) | RIF tenderness (4.5); Rebound tenderness (2.5); Migration of pain (1); No micturition difficulties (2.0); Steady pain (2); Rigidity (1) | Leucocytosis (1.5) | 98.1% at cut-off score 9; 82.9% at cut-off score 13 | 94% at cut-off score 12 | < 6: Low risk; 6-11.5: Monitoring; ≥ 12: Surgery | |
| Lintula | Gender: Male (2); female (0) | Elevated temperature (3); Rebound tenderness (7); Migration of pain (4); Vomiting (2); RIF pain (4); Guarding (4); Pain intensity: severe (2); mild or moderate (0); Bowel sounds absent, tinkling or high-pitched (4) | - | 79.0% at cut-off score 21 | 58.3% at cut-off score 21 | ≤ 15: Discharge; 16-20: Monitoring; ≥ 21: Surgery | |
| Tzanakis | - | RIF tenderness (4); Rebound tenderness (3) | Leucocytosis (2); US imaging showing appendiceal inflammation (6) | 0-4: Discharge; 5-7: Monitoring; 8-15: Surgery | |||
| Fenyo-Lindberg | Gender: Male (8); female (-8) | Rebound tenderness: Yes (5); no (-10); migration of pain to RIF: Yes (7); no (-9); Vomiting: Yes (7); no (-5); Duration of pain: < 24 h (3); > 48 h (-12); Progression of pain: Yes (3); no (-4); Aggravation with cough: Yes (4); no (-11); Rigidity: Yes (15); no (-4); Pain outside RIF: Yes (-6); no (4) | Leucocytosis, × 109/L: < 8.9 (-15); 9-13.9 (2); > 14 (10) | In a cross-sectional study including 100 patients with RIF pain, Sahu reported a sensitivity of 72% and specificity of 71% | ≤ -17: Non-specific abdominal pain; ≥ -2: AA likely | ||
| Modified Alvarado Score | - | RIF tenderness (2); Elevated temperature (1); Rebound tenderness (1); Migration of pain to RIF (1); Anorexia (1); Nausea or vomiting (1) | Leucocytosis (2) | < 5: Surgery not required; 5-6: Monitor; 7-9: Surgery indicated | |||
| Christian | - | RIF tenderness (1); Elevated temperature (1); Vomiting (1); Abdominal pain (1) | Polymorphonuclear leucocytosis (1) | < 4: Monitoring; ≥ 4: Surgery | |||
| van den Broek | Gender: Male (2) | Elevated temperature (1); Rebound tenderness (2); Duration of symptoms ≤ 48 h (1) | Leucocytosis (3) | 0-3: Observe; 4-6: Diagnostic laparoscopy | |||
| Simplified Appendicitis Score | - | RIF tenderness (1); Elevated temperature (1); Rebound tenderness (1); Migration of pain to RIF (1) | Leucocytosis (1) | < 4: AA excluded with 90.1% sensitivity; ≥ 6: AA included with 91.7% specificity | |||
RIF: Right iliac fossa; CRP: C-reactive protein; US: Ultrasound; AIR: Appendicitis inflammatory response; RIPASA: Raja Isteri Pengiran Anak Saleha.
Figure 1The key imaging features of the ultrasound scan, computed tomography scan, and magnetic resonance imaging scan.
Figure 2Special considerations in children, pregnancy, elderly and immunocompromised.